Sales rise 1.79% to Rs 22.23 crore
Net profit of Jenburkt Pharmaceuticals declined 23.53% to Rs 1.95 crore in the quarter ended June 2016 as against Rs 2.55 crore during the previous quarter ended June 2015. Sales rose 1.79% to Rs 22.23 crore in the quarter ended June 2016 as against Rs 21.84 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales22.2321.84 2 OPM %12.4216.48 -PBDT3.274.09 -20 PBT2.833.63 -22 NP1.952.55 -24Powered by Capital Market - Live News
